COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Household production and energy content of infant flours for children aged 6 to 11 months in two rural settings in southern Benin
- Breastfeeding knowledge, attitude, intention and practice of women in Purdah in Ibadan, Nigeria
- Anticarcinogenic and antioxidant activities of leaves and flowers hydroalcoholic extracts of Nerium oleander L.: PCA analysis and phytochemical content by FTIR spectroscopy
- Inactivation of E. faecalis under microwave heat treatment and ultrasound probe
- Abstract Book: Journée Internationale Bioressources au Profit de la Technologie Alimentaire (JIBTA 2021)
- Abstract Book: Séminaire international : « Environnement, Agriculture & Biotechnologie » (SIEAB – 2017)
- Anti-inflammatory activity of doum palm fruit extract used in the management of benign prostatic hyperplasia
- Regional and socio-demographic predictors of dietary proficiency of adolescent girls in Nigeria
- Does sex differ the relationship between macronutrients adequacy and aerobic power?
- Critical evaluation of the discrepancy between whole and refined foods: nutritional implications
You may also start an advanced similarity search for this article.

NAJFNR is licensed under